Quick Answer
Biomea Fusion, Inc. reported R&D Expense of $61.98 million for fiscal year 2025.
Biomea Fusion, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $61.98M | -47.5% |
| 2024 | $118.08M | +15.2% |
| 2023 | $102.55M | +63.5% |
| 2022 | $62.71M | +124.0% |
| 2021 | $28.00M | +662.6% |
| 2020 | $3.67M | +236.2% |
| 2019 | $1.09M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.40M | -47.1% | -13.1% |
| June 30, 2025 | $16.57M | -47.9% | -27.6% |
| March 31, 2025 | $22.90M | -32.2% | -16.0% |
| September 30, 2024 | $27.24M | +7.5% | -14.4% |
| June 30, 2024 | $31.82M | +45.1% | -5.8% |
| March 31, 2024 | $33.78M | +38.5% | +33.3% |
| September 30, 2023 | $25.35M | +38.9% | +15.5% |
| June 30, 2023 | $21.94M | +74.4% | -10.1% |
- Biomea Fusion, Inc. showed a decrease of -47.5% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, Biomea Fusion, Inc.’s r&d expense has grown by 5575.7% (from $1.09 million to $61.98 million).
- The most recent figure is from Biomea Fusion, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: